Liberia vs United States: Cases started on MDR-TB treatment
Liberia
162
in 2024
United States
175
in 2023
Liberia rank
54th
United States rank
53rd
Cases started on MDR-TB treatment over time
- Liberia
- United States
How they compare
United States currently reports 175 against 162 in Liberia, a difference of 13.
That makes United States's figure about 1.1 times Liberia's.
The two have swapped places 2 times across 14 shared years of data; in 2008 it was United States ahead.
Liberia ranks 54th and United States ranks 53rd of 193 countries.
United States has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Liberia | United States | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 2.5 | 64 | 61.5 | United States |
| 2010s | 36.5 | 101.38 | 64.88 | United States |
| 2020s | 97.5 | 109.75 | 12.25 | United States |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cases started on mdr-tb treatment, Liberia or United States?
- United States, at 175 against 162 in Liberia as of 2023.
- What is the difference in cases started on mdr-tb treatment between Liberia and United States?
- 13, with United States ahead.
- How many years of comparable data are there for Liberia and United States?
- 14 years are reported by both, from 2008 to 2023.
- How do Liberia and United States rank globally for cases started on mdr-tb treatment?
- Liberia ranks 54th and United States ranks 53rd of 193 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Cases started on MDR-TB treatment. Statizoid refreshes it automatically from the source and publishes the full history for both places.